A case of malignant melanoma after repeated recurrent dysplastic nevi
- PMID: 31462019
- PMCID: PMC6715558
- DOI: 10.7181/acfs.2019.00283
A case of malignant melanoma after repeated recurrent dysplastic nevi
Abstract
Dysplastic nevus is common and affects about 10% of the northern European-descendent population. Studies over the past several decades have identified dysplastic nevi as a risk factor for malignant melanoma. Furthermore, in rare cases, they confirmed that dysplastic nevi have progressed to melanoma. Cases in which dysplastic nevi progressed to malignant melanoma in multiple studies are not uncommon. A 35-year-old woman presented with the major symptom of multiple itchy brown nodules (2.0 cm× 1.3 cm) in the left cheek that had first appeared 20 years earlier. Complete excision was performed at the first visit; subsequent biopsy confirmed that they were dysplastic nevi. They recurred three times over 3 years at the same site, all of which were histologically diagnosed as dysplastic nevi. Five years after the final excision, a brownish nodule developed in the left cheek, with others at the left temporal region, right retroauricular region, and left shoulder at the same time. These lesions were histologically diagnosed as malignant melanoma. We experienced a case of malignant melanoma that occurred at the same site after three recurrences of dysplastic nevi. Although rare, the possibility of malignant melanoma should be considered in follow-ups in cases involving repeatedly recurrent dysplastic nevi.
Keywords: Dysplastic nevus syndrome; Melanoma; Recurrence.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Carey WP, Jr, Thompson CJ, Synnestvedt M, Guerry D 4th, Halpern A, Schultz D, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer. 1994;74:3118–25. - PubMed
-
- Burden AD, Newell J, Andrew N, Kavanagh G, Connor JM, MacKie RM. Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol. 1999;135:261–5. - PubMed
-
- Masri GD, Clark WH, Jr, Guerry D 4th, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol. 1990;22(6 Pt 1):1042–8. - PubMed
-
- Weinstock MA, Barnhill RL, Rhodes AR, Brodsky GL. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel Arch Dermatol. 1997;133:953–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
